Effect of Glossopharyngeal Versus Diaphragmatic Breathing Exercise on Pulmonary Function After Decortication Surgery

NCT06518759 | Completed

• 1 other identifier: P.T.REC/012/003896
• Study Type: interventional
• Target: 60
• Locations: 1 country
• Sites: 1

Brief Summary

This study will be conducted to compare between the effect of glossopharyngeal and diaphragmatic breathing exercises on pulmonary functions after decortication surgery

Conditions

Pulmonary Disease

Outcome Measures

Primary Outcomes (8)

• Tidal volume

  The spirometer device (Meditech, made in China) will be used to measure tidal volume for all participants in all groups before and after the treatment program. It is the amount of air that moves in or out of the lungs with each respiratory cycle. It measures about 400 ml in a healthy female.

  within 2 weeks

• Inspiratory reserve volume (IRV)

  The spirometer device (Meditech, made in China) will be used to measure inspiratory reserve volume (IRV) for all participants in all groups before and after the treatment program. \- IRV: It is the amount of air that can be forcibly inhaled after normal tidal volume. The normal adult value is 1900-3300 ml.

  within 2 weeks

• Expiratory reserve volume (ERV)

  The spirometer device (Meditech, made in China) will be used to measure expiratory reserve volume (ERV) for all participants in all groups before and after the treatment program. ERV: It is the amount of extra air above normal breath-exhaled during forceful breath out, its average is about 800ml in females.

  within 2 weeks

• Measurement of the potential of hydrogen (PH)

  Blood gas analyzer will be used to measure the potential of hydrogen (PH) for all participants in all groups before and after the treatment program. The blood sample was taken from the radial or brachial or femoral artery or from arterial catheter and put in the device. The normative value of pH is7.35-7.45

  within 2 weeks

• Measurement of the partial arterial pressure of carbon dioxide(PaCO2)

  Blood gas analyzer will be used to measure the partial arterial pressure of carbon dioxide(PaCO2) for all participants in all groups before and after the treatment program. The blood sample was taken from the radial or brachial or femoral artery or from arterial catheter and put in the device. the normative value of PaCO2 is 4.7-6 KPa.

  within 2 weeks

• Measurement of the partial arterial pressure of oxygen (PaO2)

  Blood gas analyzer will be used to measure the partial arterial pressure of oxygen (PaO2)for all participants in all groups before and after the treatment program. The blood sample was taken from the radial or brachial or femoral artery or from arterial catheter and put in the device. the normative value of Pao2 is 1.7-13.3 KPa.

  within 2 weeks

• Measurement of the Bicarbonate (HCO3)

  Blood gas analyzer will be used to measure the Bicarbonate (HCO3) for all participants in all groups before and after the treatment program. The blood sample was taken from the radial or brachial or femoral artery or from arterial catheter and put in the device. The normative value of HCO3 is 22-26 mmol/L.

  within 2 weeks

• Measurement of oxygen saturation (SO2)

  Blood gas analyzer will be used to measure oxygen saturation (SO2) for all participants in all groups before and after the treatment program. The blood sample was taken from the radial or brachial or femoral artery or from arterial catheter and put in the device. The normative value of SO2 is 95-100%..

  within 2 weeks

Study Arms (3)

Traditional chest techniques

ACTIVE COMPARATOR

the patients will receive traditional chest techniques only

Other: traditional chest techniques

Traditional chest techniques +Glossopharyngeal breathing exercise

EXPERIMENTAL

the patients will receive traditional chest techniques and glossopharyngeal breathing exercise

Other: traditional chest techniques; Other: Glossopharyngeal breathing exercise

Traditional chest techniques +diaphragmatic breathing exercise

EXPERIMENTAL

the patients will receive traditional chest techniques and diaphragmatic breathing exercise

Other: traditional chest techniques; Other: Diaphragmatic breathing exercise

Interventions

traditional chest techniques OTHER

patients will receive traditional chest techniques in the form of percussion and vibration, 2 times per day, 3 sets 5 repetitions per each set for 20 minutes, 3 times per week for 2 weeks

Traditional chest techniques; Traditional chest techniques +Glossopharyngeal breathing exercise; Traditional chest techniques +diaphragmatic breathing exercise

Glossopharyngeal breathing exercise OTHER

patients will receive Glossopharyngeal breathing exercise, 2 times per day, 3 sets 5 repetitions per each set for 20 minutes, 3 times per week for 2 weeks.

Traditional chest techniques +Glossopharyngeal breathing exercise

Diaphragmatic breathing exercise OTHER

patients will receive diaphragmatic breathing exercise, 2 times per day, 3 sets 5 repetitions per each set for 20 minutes, 3 times per week for 2 weeks.

Traditional chest techniques +diaphragmatic breathing exercise

Eligibility Criteria

• Age: 40 Years - 50 Years
• Sex: female
• Healthy Volunteers: Yes
• Age Groups: Adult (18-64)

You may qualify if:

• The participant's body mass index (BMI) will be ranged from 25- 29.9 kg/m2
• The patient will receive treatment after 24 hours after decortication
• The study will be in the intensive care unit (ICU).
• The patients have unilateral lung decortication
• Their vital capacity is 70% or less.

You may not qualify if:

• Cancerous patient.
• Inability to comprehend and follow instructions as in dementia
• paralytic involvement of thorax muscle
• Abdominal diseases that affect diaphragmatic function
• Diaphragmatic paralysis

Sponsors & Collaborators

• Cairo University: lead

Study Sites (1)

Mai Gamal El-Din Mostafa

Cairo, Egypt

Location

MeSH Terms

Conditions

Lung Diseases

Condition Hierarchy (Ancestors)

Respiratory Tract Diseases

Study Officials

• Nesreen El-Nahas, professor

  Cairo University

  STUDY CHAIR

Study Design

• Study Type: interventional
• Phase: not applicable
• Allocation: RANDOMIZED
• Masking: SINGLE
• Who Masked: OUTCOMES ASSESSOR
• Purpose: TREATMENT
• Intervention Model: PARALLEL
• Sponsor Type: OTHER
• Responsible Party: PRINCIPAL INVESTIGATOR
• PI Title: Principal investigator

Study Record Dates

• First Submitted: July 17, 2024
• First Posted: July 24, 2024
• Study Start: July 30, 2024
• Primary Completion: March 15, 2025
• Study Completion: March 31, 2025
• Last Updated: April 17, 2025

Record last verified: 2024-07

Data Sharing

• IPD Sharing: Will share
• Shared Documents: STUDY PROTOCOL

Locations

EG (1)